<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Evaluating the energy regulatory hormones of nesfatin-1, irisin, adropin and preptin in multiple sclerosis

Loading...
Thumbnail Image

Institution Authors

Organizational Units

Organizational Units

Advisor

Editor

Journal Title

Journal ISSN

Volume Title

Type:

Publisher

Elsevier BV

DOI

10.1016/j.msard.2022.104221

Abstract

Nesfatin-1, irisin, adropin and preptin were originally introduced as energy regulatory hormones. However, the results of studies revealed that these hormones may also have important roles in inflammation, immune function and neurological impairment. Multiple sclerosis (MS) is a chronic autoimmune disease, characterized by progressive inflammation, demyelination, and axonal loss in the central nervous system. We aimed to evaluate nesfatin-1, irisin, adropin and preptin hormones in patients with MS accompanied by inflammation and central nervous system dysfunction.A total of 110 subjects (65 patients with relapsing-remitting MS and 45 healthy individuals as control group) were included in this study. Venous blood samples were collected between 7:30 a.m. and 9:00 a.m. Serum concentrations of all markers were measured by enzyme linked immunoassay methods. The unpaired t-test was used to investigate between-group differences.The nesfatin-1, irisin, adropin and preptin levels were found to be significantly lower in the MS group compared to the control group (p < 0.05).In the present study, circulating nesfatin-1, irisin, adropin and preptin levels were decreased in patients with MS. However, the pathogenesis of MS and the underlying molecular mechanism of these hormones in MS have still not been elucidated. Further investigations with larger sample sizes and longer periods are required to obtain satisfactory information. In conclusion, the energy regulatory hormones of nesfatin-1, irisin, adropin and preptin may have potential for the development of new therapeutic targets for treatment of inflammatory diseases.

Description

Journal or Series

Multiple Sclerosis and Related Disorders

ISSN

2211-0348

ISBN

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By

Rights and licensing

info:eu-repo/semantics/closedAccess

Research Projects

Journal Issue

Related Patent

Google Scholar
Scholar'da Ara ↗
Altmetric
Dimensions
PlumX Metrikleri
BIP! Indicators